logo
Top Stories
56
45
amazoan-manchester-101918-lg.jpg

Amazon.com Inc. (AMZN) said it plans to open a new corporate office in Manchester in 2019 and also create more than 1,000 highly-skilled jobs in the UK. As part of the ramp up of its UK investment, Amazon will increase the capacity of its Scotland...

existing-home-sales-101918-lg.jpg

After a month of stagnation in August, the National Association of Realtors released a report on Friday showing existing home sales in the U.S. tumbled by much more than anticipated in the month of September. NAR said existing home sales plunged by...

greggianforte-101918-lg.jpg

Despite the recent attention on the safety of journalists after the apparent murder of Saudi critic Jamal Khashoggi, President Donald Trump on Thursday offered praise for a Republican Congressman accused of assaulting a reporter last year.

wallstreet3_19oct18-lg.jpg

After failing to sustain an early move to the upside, stocks turned mixed over the course of the trading session on Friday. The major averages pulled back well off their highs of the session, with the Nasdaq and the S&P 500 ending the day in negative...

manbooker-oct17-lg.jpg

Northern Ireland's Anna Burns won this year's Man Booker Prize for her novel, "Milkman." Anna, 56, becomes the first Northern Irish writer, and the first woman since 2013, to win the prestigious world literature award. Milkman is Anna's third...

pharma-012617_14oct18.jpg Today's Daily Dose brings you news about AcelRx Pharma's pain medication DSUVIA getting thumbs up from FDA panel; near-term catalyst of Auris Medical; regulatory nod for Grifols' ID CORE XT kit for molecular red blood cell typing; Iovance' public offering and Tandem's t:slim X2 Insulin Pump approval in Canada.
asian-mixed2_14oct18.jpg Asian stock markets are mostly lower on Monday despite the positive cues from Wall Street Friday as investors treaded cautiously amid worries about global economic growth and on Saudi Arabia's rising diplomatic tensions with the West following the disappearance as well as suspected murder of Washington Post columnist Jamal Khashoggi. Crude oil prices also rose in Asian trading.
asian-markets2_15oct18.jpg European stocks may open flat to slightly lower on Monday as worries about global trade and economic growth persist. Asian markets are mostly lower, with Japanese shares leading regional losses on the buzz that Prime Minister Shinzo Abe would later...
markets-111714_15oct18.jpg Asian stocks fell on Monday to extend last week's slide, as worries about global trade and higher U.S. interest rates lingered. A growing feud between the U.S. and Saudi Arabia over the disappearance of a prominent Saudi journalist also weighed on investors'...
Read More
greggianforte-101918.jpg Despite the recent attention on the safety of journalists after the apparent murder of Saudi critic Jamal Khashoggi, President Donald Trump on Thursday offered praise for a Republican Congressman accused of assaulting a reporter last year.
Read More
greggianforte-101918.jpg Despite the recent attention on the safety of journalists after the apparent murder of Saudi critic Jamal Khashoggi, President Donald Trump on Thursday offered praise for a Republican Congressman accused of assaulting a reporter last year.
Read More
chinagdp-oct19.jpgChina's economy grew at the slowest pace since the global financial crisis in 2009 reflecting softening activity across manufacturing and investment amid escalating trade tensions and government's measures to rein in excessive lending. Gross domestic product expanded 6.5 percent year-on-year in the third quarter, slower than the 6.7 percent growth seen in the second quarter, the National Bureau
Read More
Cryptocurrencies opened the week with solid gains, as worries that the controversial stablecoin Tether would fail to defend its 1:1 peg to the dollar likely prompted investors in that altcoin to shift their money to safe-havens such as Bitcoin and Ethereum. Here is a collection of the main stories from the cryptocurrency and blockchain space this week. Read More
As we head into another month of new drug approvals, it's time to take a look at some of the FDA-related news that grabbed headlines in September. Seeking to curb the sharp rise in the number of teens using e-cigarettes, the FDA, has expanded its Youth Tobacco Prevention Plan, which was first introduced last April. Read More
Novartis (NVS) announced positive results from the global Phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) in combination with fulvestrant. The trial evaluated the efficacy and safety of alpelisib... Read More
ticketing-oct19.jpg Global live event ticketing giant Ticketmaster acquired blockchain ticketing company Upgraded. The acquisition will enable Ticketmaster to provide blockchain-powered ticketing to protect customers against fraudulent tickets. Upgraded said it converts traditional event tickets into secure interactive digital smart tickets protected by blockchain.
Read More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
10/19/18 13:0Baker Hughes - Rig CountOCT 19 United States
10/19/18 10:0Existing Home Sales - PriceSEP United States
10/19/18 10:0Existing Home Sales - SalesSEP United States
10/19/18 10:0Existing Home Sales - InventoriesSEP United States
10/19/18 9:0Consumer Confidence IndexOCT Belgium
10/19/18 8:30Retail Sales - Ex. Auto (Y-o-Y)AUG Canada
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
01/18/19IMMUSacituzumab govitecan (BLA)FDA decision on Sacituzumab govitecan for treatment of metastatic triple-negative breast cancer
01/05/19ACORINBRIJA (NDA)FDA decision on INBRIJA as a treatment for symptoms of OFF periods in people with Parkinson’s disease taking a carbidopa/levodopa regimen.
12/31/18PTLAAndexxa Prior Approval Supplement FDA decision on Andexxa for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed
12/24/18RHHBYBaloxavir Marboxil (NDA)FDA decision on Baloxavir Marboxil for the treatment of acute, uncomplicated influenza in people 12 years and older
12/21/18SHPG, SHP.LPrucalopride (NDA)FDA decision on Prucalopride as a potential once-daily treatment option for chronic idiopathic constipation in adults
View All